Biological Changes in the Adipose Tissue Among Pregnant Women With Diabetes
NCT ID: NCT02383537
Last Updated: 2016-09-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
150 participants
OBSERVATIONAL
2017-04-30
2020-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Maternal Adipose Tissue and Placental Dysfunction Programs the Fetus for Type 2 Diabetes (PlacentA-DM)
NCT02211651
Telocytes in Placental Tissues of Patients With Gestational and Pre-gestational Diabetes
NCT05305326
Fat Metabolism in Pregnancy and Neonatal Heart Function in Diabetes
NCT01346527
Role of Liver and Visceral Fat in Glucose and Lipid Metabolism During Pregnancy
NCT02282475
Possible Epigenetic Changes in Offspring of Women With Pregestational and Gestational Diabetes
NCT01255384
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. fat tissue, Umbilical cord blood, placenta tissue and subcutaneous fat will be taken from pregnant diabetic woman over going a C-section.
2. Bloods will be analyzed for insulin, c-peptide, glucose and fat profile
3. Placenta and fat tissue will be analyzed for miRNA and total RNA
4. Clinical and anthropometric measurements will be taken from the mother
5. Placenta status will be taken
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pregnant women with diabetes
Pregnant women with diabetes type 1, type 2 or gestational diabetes
Diabetes
the trial is observational with no intervention
Healthy pregnant women
Healthy pregnant women with no underlying illness
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diabetes
the trial is observational with no intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* pregnant
* signed consent form
* going through an elective C-section
* Diabetic
* reference group: healthy women with no background illness
Exclusion Criteria
* chronic illness that may effect the outcome
* polypharmacy
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hadassah Medical Organization
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Uriel Elchalal, Professor
Role: PRINCIPAL_INVESTIGATOR
Hadassah Ein Keren
Ram Weiss, Professor
Role: PRINCIPAL_INVESTIGATOR
Hebrew University
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0633-14-HMO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.